Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,078 | 302 | 96.4% |
| Education | $152.98 | 2 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $930.43 | 78 | $0 (2023) |
| ABBVIE INC. | $638.44 | 46 | $0 (2022) |
| Janssen Biotech, Inc. | $495.37 | 22 | $0 (2022) |
| PFIZER INC. | $467.11 | 60 | $0 (2022) |
| UCB, Inc. | $316.34 | 16 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $265.53 | 15 | $0 (2022) |
| GlaxoSmithKline, LLC. | $193.02 | 12 | $0 (2022) |
| Mallinckrodt Hospital Products Inc. | $189.45 | 10 | $0 (2023) |
| Lilly USA, LLC | $187.72 | 12 | $0 (2022) |
| Genentech USA, Inc. | $142.77 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $77.24 | 4 | Amgen Inc. ($55.62) |
| 2022 | $2,718 | 197 | Amgen Inc. ($516.62) |
| 2021 | $1,436 | 103 | Amgen Inc. ($358.19) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/17/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Bone Health | ||||||
| 01/04/2023 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Inflammation | ||||||
| 01/03/2023 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Inflammation | ||||||
| 12/22/2022 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/20/2022 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: BioOncology/Immunology | ||||||
| 12/20/2022 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: BioOncology/Immunology | ||||||
| 12/20/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/15/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Immunology | ||||||
| 12/14/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $3.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/13/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Inflammation | ||||||
| 12/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Inflammation | ||||||
| 12/01/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Immunology | ||||||
| 12/01/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Immunology | ||||||
| 11/30/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/23/2022 | AstraZeneca Pharmaceuticals LP | EVUSHELD (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Vaccines & Immune Therapies | ||||||
| 11/22/2022 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: Inflammation | ||||||
| 11/16/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $34.39 | General |
| Category: Immunology | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $64.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/15/2022 | PFIZER INC. | XELJANZ (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $1.30 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/09/2022 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 73 | 8,073 | $162,336 | $31,105 |
| 2022 | 8 | 545 | 156,313 | $3.5M | $895,320 |
| 2021 | 14 | 693 | 178,408 | $2.1M | $1.0M |
| 2020 | 13 | 788 | 229,081 | $2.6M | $1.4M |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 20 | 8,000 | $152,000 | $30,245 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 32 | $9,024 | $488.65 | 5.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 41 | $1,312 | $371.26 | 28.3% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 65 | 149,601 | $2.7M | $678,656 | 25.1% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 12 | 3,875 | $555,500 | $134,360 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 198 | 736 | $182,171 | $53,811 | 29.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 960 | $42,384 | $16,334 | 38.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 79 | 764 | $29,184 | $7,057 | 24.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 26 | 106 | $15,447 | $4,562 | 29.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 122 | 163 | $3,420 | $483.72 | 14.1% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 29 | 108 | $1,023 | $56.95 | 5.6% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 62 | 133,201 | $1.6M | $768,357 | 48.1% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2021 | 12 | 42,000 | $294,000 | $184,314 | 62.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 182 | 552 | $105,984 | $42,858 | 40.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 15 | 1,320 | $37,440 | $21,639 | 57.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 102 | 734 | $35,232 | $6,729 | 19.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 20 | 92 | $12,696 | $4,260 | 33.6% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 13 | 38 | $20,064 | $2,402 | 12.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 51 | $7,344 | $2,318 | 31.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 38 | 112 | $2,016 | $887.39 | 44.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 106 | 152 | $2,736 | $453.00 | 16.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 34 | 40 | $2,200 | $422.40 | 19.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 17 | 17 | $374.00 | $132.09 | 35.3% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2021 | 36 | 42 | $504.00 | $113.40 | 22.5% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2021 | 19 | 57 | $293.00 | $31.32 | 10.7% |
About Nancy Trotter, NP
Nancy Trotter, NP is a Nurse Practitioner healthcare provider based in Provo, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881682086.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nancy Trotter, NP has received a total of $4,231 in payments from pharmaceutical and medical device companies, with $77.24 received in 2023. These payments were reported across 304 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,078).
As a Medicare-enrolled provider, Trotter has provided services to 2,099 Medicare beneficiaries, totaling 571,875 services with total Medicare billing of $3.3M. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Provo, UT
- Active Since 10/11/2005
- Last Updated 12/15/2009
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1881682086
Products in Payments
- Enbrel (Biological) $743.33
- RINVOQ (Biological) $502.16
- XELJANZ (Drug) $452.03
- Cimzia (Drug) $316.34
- TREMFYA (Drug) $270.38
- REMICADE (Biological) $224.99
- BENLYSTA (Biological) $193.02
- ACTHAR (Biological) $189.45
- TALTZ (Drug) $187.72
- SAPHNELO (Biological) $181.69
- EVENITY (Biological) $159.20
- Rituxan (Biological) $107.91
- EVUSHELD (Drug) $69.45
- RENFLEXIS (Drug) $69.28
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $68.94
- SKYRIZI (Biological) $66.93
- HUMIRA (Biological) $54.74
- OFEV (Drug) $41.53
- KINERET (Drug) $40.11
- Tymlos (Biological) $39.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Provo
Steven Larsen, Np, NP
Nurse Practitioner — Payments: $8,396
James Biesinger, Np, NP
Nurse Practitioner — Payments: $7,329
Tracy Williams, A.p.r.n, A.P.R.N
Nurse Practitioner — Payments: $6,780
Valerie Juarez, Aprn, APRN
Nurse Practitioner — Payments: $5,319
Ann Rogerson, Np, NP
Nurse Practitioner — Payments: $3,544
Robert Harkness, Np, NP
Nurse Practitioner — Payments: $3,491